These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

297 related articles for article (PubMed ID: 27993095)

  • 21. 90Y Radioembolization of Colorectal Hepatic Metastases Using Glass Microspheres: Safety and Survival Outcomes from a 531-Patient Multicenter Study.
    Hickey R; Lewandowski RJ; Prudhomme T; Ehrenwald E; Baigorri B; Critchfield J; Kallini J; Gabr A; Gorodetski B; Geschwind JF; Abbott A; Shridhar R; White SB; Rilling WS; Boyer B; Kauffman S; Kwan S; Padia SA; Gates VL; Mulcahy M; Kircher S; Nimeiri H; Benson AB; Salem R
    J Nucl Med; 2016 May; 57(5):665-71. PubMed ID: 26635340
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A Microdosimetric Analysis of Absorbed Dose to Tumor as a Function of Number of Microspheres per Unit Volume in 90Y Radioembolization.
    Pasciak AS; Bourgeois AC; Bradley YC
    J Nucl Med; 2016 Jul; 57(7):1020-6. PubMed ID: 26912424
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Radioembolization with selective internal radiation microspheres for neuroendocrine liver metastases.
    King J; Quinn R; Glenn DM; Janssen J; Tong D; Liaw W; Morris DL
    Cancer; 2008 Sep; 113(5):921-9. PubMed ID: 18618495
    [TBL] [Abstract][Full Text] [Related]  

  • 24. 90Y Radioembolization after radiation exposure from peptide receptor radionuclide therapy.
    Ezziddin S; Meyer C; Kahancova S; Haslerud T; Willinek W; Wilhelm K; Biersack HJ; Ahmadzadehfar H
    J Nucl Med; 2012 Nov; 53(11):1663-9. PubMed ID: 22988059
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Radioembolization with 90yttrium microspheres: a state-of-the-art brachytherapy treatment for primary and secondary liver malignancies. Part 2: special topics.
    Salem R; Thurston KG
    J Vasc Interv Radiol; 2006 Sep; 17(9):1425-39. PubMed ID: 16990462
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Yttrium-90 resin microsphere radioembolization using an antireflux catheter: an alternative to traditional coil embolization for nontarget protection.
    Morshedi MM; Bauman M; Rose SC; Kikolski SG
    Cardiovasc Intervent Radiol; 2015 Apr; 38(2):381-8. PubMed ID: 24989143
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Optimization of radioembolic effect with extended-shelf-life yttrium-90 microspheres: results from a pilot study.
    Lewandowski RJ; Riaz A; Ryu RK; Mulcahy MF; Sato KT; Kulik LM; Gates VL; Baker T; Omary R; Salem R
    J Vasc Interv Radiol; 2009 Dec; 20(12):1557-63. PubMed ID: 19854068
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Hepatic radioembolization with Yttrium-90 glass microspheres for treatment of primary liver cancer.
    Cao X; He N; Sun J; Tan J; Zhang C; Yang J; Lu T; Li J
    Chin Med J (Engl); 1999 May; 112(5):430-2. PubMed ID: 11593513
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Evaluation of factors affecting tumor response and survival in patients with primary and metastatic liver cancer treated with microspheres.
    Demirelli S; Erkilic M; Oner AO; Budak ES; Gunduz S; Ozgur O; Bozcuk H; Sindel HT; Boz A
    Nucl Med Commun; 2015 Apr; 36(4):340-9. PubMed ID: 25563137
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Microsphere localization and dose quantification using positron emission tomography/CT following hepatic intraarterial radioembolization with yttrium-90 in patients with advanced hepatocellular carcinoma.
    Lea WB; Tapp KN; Tann M; Hutchins GD; Fletcher JW; Johnson MS
    J Vasc Interv Radiol; 2014 Oct; 25(10):1595-603. PubMed ID: 25156647
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A descriptive analysis of remnant activity during (90)Y resin microspheres radioembolization of hepatic tumors: technical factors and dosimetric implications.
    Rodríguez LS; Thang SP; Li H; Khor LK; Tay YS; Myint KO; Tong AK
    Ann Nucl Med; 2016 Apr; 30(3):255-61. PubMed ID: 26692012
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hepatic radioembolization with yttrium-90 containing glass microspheres: preliminary results and clinical follow-up.
    Andrews JC; Walker SC; Ackermann RJ; Cotton LA; Ensminger WD; Shapiro B
    J Nucl Med; 1994 Oct; 35(10):1637-44. PubMed ID: 7931662
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Safety of repeated yttrium-90 radioembolization.
    Lam MG; Louie JD; Iagaru AH; Goris ML; Sze DY
    Cardiovasc Intervent Radiol; 2013 Oct; 36(5):1320-8. PubMed ID: 23354961
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Long-Term Hepatotoxicity of Yttrium-90 Radioembolization as Treatment of Metastatic Neuroendocrine Tumor to the Liver.
    Su YK; Mackey RV; Riaz A; Gates VL; Benson AB; Miller FH; Yaghmai V; Gabr A; Salem R; Lewandowski RJ
    J Vasc Interv Radiol; 2017 Nov; 28(11):1520-1526. PubMed ID: 28673658
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Outpatient single-session yttrium-90 glass microsphere radioembolization.
    Gates VL; Marshall KG; Salzig K; Williams M; Lewandowski RJ; Salem R
    J Vasc Interv Radiol; 2014 Feb; 25(2):266-70. PubMed ID: 24332243
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Feasibility of Liver Transplantation after 90 Y Radioembolization: Lessons from a Radiation Protection Incident.
    Soret M; Maisonobe JA; Maksud P; Payen S; Allaire M; Savier E; Roux C; Lussey-Lepoutre C; Kas A
    Health Phys; 2024 Sep; 127(3):373-377. PubMed ID: 38535982
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Procedures, spectrum and radiation exposure in CT-fluoroscopy].
    Stoeckelhuber BM; Schulz E; Melchert UH; Blobel J; Gellissen J; Gehl H; Weiss HD; Leibecke T
    Rontgenpraxis; 2003; 55(2):51-7. PubMed ID: 14618963
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Radiation exposure to operating room personnel and patients during endovascular procedures.
    Mohapatra A; Greenberg RK; Mastracci TM; Eagleton MJ; Thornsberry B
    J Vasc Surg; 2013 Sep; 58(3):702-9. PubMed ID: 23810300
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Yttrium-90 radioembolization of malignant tumors of the liver: gallbladder effects.
    Sag AA; Savin MA; Lal NR; Mehta RR
    AJR Am J Roentgenol; 2014 May; 202(5):1130-5. PubMed ID: 24758670
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Yttrium-90 Radioembolization in the VX2 Rabbit Model: Radiation Safety and Factors Influencing Delivery Efficiency.
    Gordon AC; Gates VL; White SB; Harris KR; Mouli SK; Kim DH; Omary RA; Salem R; Lewandowski RJ; Larson AC
    J Vasc Interv Radiol; 2021 Nov; 32(11):1569-1574.e11. PubMed ID: 34717835
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.